Mericks Pharmaceuticals Private Limited

Mericks Pharmaceuticals Private Limited - pharma in Ambala Cantt, Haryana, India. FY 2026 financials & compliance.
CIN U24303HR2020PTC086822 Incorporated 16 June 2020 ROC Haryana HQ Ambala Cantt, Haryana, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹16.25 Lakh
▲ 26% YoY
Net profit · FY 2025
₹1,175
Net margin 0.1%
EBITDA · FY 2025
₹3,000
EBITDA margin 0.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Mericks Pharmaceuticals Private Limited

Data last updated:

Mericks Pharmaceuticals Private Limited is a private limited company based in Ambala Cantt, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 June 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24303HR2020PTC086822.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gaurav Rai and Shikha Rai.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 171 Hsidc Saha, Ambala Cantt, Haryana, India – 133001.

As per the financials filed for FY 2025, the company reported a revenue of ₹16.25 Lakh, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹1,175 (net margin 0.1%) and EBITDA of ₹3,000 (EBITDA margin 0.2%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years.

Mericks Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-01-0000042).

Company details

CIN U24303HR2020PTC086822
Registration Number 086822
Incorporation Date 16 June 2020
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-HR-01-0000042
Key People
Gaurav Rai Director Shikha Rai Director

Recognitions & Rankings of Mericks Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2020-21)
Udyam number
UDYAM-HR-01-0000042

Contact details

Mericks Pharmaceuticals Private Limited's registered office is in Ambala Cantt, Haryana. Its e-mail address is in the company report.

  • Email
  • Registered Address
    171 Hsidc Saha, Ambala Cantt, Haryana, India – 133001
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Mericks Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Mericks Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Mericks Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Mericks Pharmaceuticals Private Limited, buy the company report.

Financials of Mericks Pharmaceuticals Private Limited

FY 2025 filings available

Mericks Pharmaceuticals Private Limited reported revenue of ₹16.25 Lakh (up 26% YoY) for FY 2025.

Revenue · FY 2025
₹16.25 Lakh ▲ 26%
Net profit · FY 2025
₹1,175 margin 0.1%
EBITDA · FY 2025
₹3,000 margin 0.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 26%
3 years · compounded
▲ 24%
EBITDA CAGR growth
1 year
▼ 3%
3 years · compounded
▼ 28%

Revenue has grown at a compounded annual rate (CAGR) of 24% over three years, including 26% growth in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3,000
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1,175
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin0.2%
Net Profit Margin0.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Mericks Pharmaceuticals Private Limited, buy the company report.

Board of directors of Mericks Pharmaceuticals Private Limited

Mericks Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Gaurav RaiDirector16 Jun 20206 Years 4 MonthsCurrent
Shikha RaiDirector16 Jun 20206 Years 4 MonthsCurrent
View all directors

Peer comparison

Mericks Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Madhura Pharmaceuticals Private Limited₹16.3 Lakh (FY 2025)239.0%Coimbatore, Tamil Nadu, India
MDB Pharmaceuticals Private Limited₹16.26 Lakh (FY 2025)Gurgaon, Haryana, India
Arka Formulations Private Limited₹16.26 Lakh (FY 2024)252.0%Hyderabad, Telangana, India
Mericks Pharmaceuticals Private Limitedthis company₹16.25 Lakh (FY 2025)₹1,1750.1%26.0%Ambala Cantt, Haryana, India
Remalthea Pharmaceuticals Private Limited₹16.24 Lakh (FY 2025)-8.0%Aurangabad, Maharashtra, India
Ajapa Pharma Private Limited₹16.2 Lakh (FY 2020)120.0%Hyderabad, Telangana, India

To see the full peer comparison of Mericks Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Mericks Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Mericks Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 05, 2024.

Active EPFO establishments
1

GST

No GST registration is on our record for Mericks Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Mericks Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Gaurav Rai was appointed as Director on 16 Jun 2020.

AGM
Mericks Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Mericks Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Appointed
Gaurav Rai was appointed as Director.
Appointed
Shikha Rai was appointed as Director.
Incorporation
16 Jun 2020
Mericks Pharmaceuticals Private Limited was registered on 16 Jun 2020 with Roc Haryana & aged 6 years 4 months as per MCA records.

Frequently asked questions

Mericks Pharmaceuticals is an active private limited company based in Ambala Cantt, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 June 2020 (6+ years old) and is registered under CIN U24303HR2020PTC086822.

Mericks Pharmaceuticals has 2 current directors:

The latest financial statements of Mericks Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The CIN (Corporate Identification Number) of Mericks Pharmaceuticals is U24303HR2020PTC086822. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Mericks Pharmaceuticals was incorporated on 16 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Haryana.

The peers of Mericks Pharmaceuticals by revenue are Madhura Pharmaceuticals Private Limited, MDB Pharmaceuticals Private Limited, Arka Formulations Private Limited, Remalthea Pharmaceuticals Private Limited, Ajapa Pharma Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).

Gaurav Rai was appointed as Director on 16 Jun 2020. Shikha Rai was appointed as Director on 16 Jun 2020.

Yes, Mericks Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-01-0000042).

The registered office of Mericks Pharmaceuticals is at 171 Hsidc Saha, Ambala Cantt, Haryana, India – 133001.

Mericks Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

Mericks Pharmaceuticals can be reached at its registered office: 171 Hsidc Saha, Ambala Cantt, Haryana, India – 133001.